Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
2021
Abstract Background Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a monoclonal ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
23
References
244
Citations
NaN
KQI